Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Classys (214150 KS): Solid Start to 2025; Global Expansion Continues; Stake Sale Overhang to Remain

Classys (214150 KS): Equipment Sale Boosts 2Q Result; New Device Approval to Drive 2H Performance

Classys (214150 KS): Stellar 3Q Result; 2025 Guidance Reaffirmed; Brazil Is Set to Recover from 4Q

Merger Between Classys and Ilooda Likely to Reduce Local Competition

Classys: One of Korea's Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends

Classys (214150 KS): 2024 Sales Beat Guidance; New Record Sales Target for 2025

Classys (214150 KS): Record High Sales in 3Q24; Volnewmer Led Performance Growth; US Launch Begins

Classys (214150 KS): Solid 2Q24 Result Fuelled by Strong Demand for Aesthetic Medical Devices

Douglas Research Advisory

Event-Driven

<ul>
<li>After the market close on 16 May, Bain Capital sold about 6% stake in Classys (214150 KS) in a block deal sale.</li>
<li>Bain Capital sold 3.93 million shares of Classys at 57,915 won per share (this price is 10.9% discount from Classys’ closing price the previous day).</li>
<li><em><strong>Bain Capital’s decision to sell a 6% stake in Classys via a discounted block deal, rather than offloading its entire 60.2% controlling stake, indicates a share overhang on future sales. </strong></em></li>
</ul>


After the market close on 16 May, Bain Capital sold about 6% stake in Classys (214150 KS) in a block deal sale.
Bain Capital sold 3.93 million shares of Classys at 57,915 won per share (this price is 10.9% discount from Classys’ closing price the previous day).
Bain Capital’s decision to sell a 6% stake in Classys via a discounted block deal, rather than offloading its entire 60.2% controlling stake, indicates a share overhang on future sales. 


Classys: Block Deal Sale of 6% By Bain Capital Raises Overhang Concerns